Roden et al., 2006 - Google Patents
Pharmacogenomics: challenges and opportunitiesRoden et al., 2006
View HTML- Document ID
- 17051888254589630345
- Author
- Roden D
- Altman R
- Benowitz N
- Flockhart D
- Giacomini K
- Johnson J
- Krauss R
- McLeod H
- Ratain M
- Relling M
- Ring H
- Shuldiner A
- Weinshilboum R
- Weiss S
- Pharmacogenetics Research Network
- Publication year
- Publication venue
- Annals of internal medicine
External Links
Snippet
The outcome of drug therapy is often unpredictable, ranging from beneficial effects to lack of efficacy to serious adverse effects. Variations in single genes are 1 well-recognized cause of such unpredictability, defining the field of pharmacogenetics (see Glossary). Such variations …
- 230000002974 pharmacogenomic 0 title abstract description 63
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/22—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for sequence comparison involving nucleotides or amino acids, e.g. homology search, motif or SNP [Single-Nucleotide Polymorphism] discovery or sequence alignment
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/20—Handling natural language data
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation, e.g. computer aided management of electronic mail or groupware; Time management, e.g. calendars, reminders, meetings or time accounting
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Roden et al. | Pharmacogenomics: challenges and opportunities | |
Pirmohamed | Pharmacogenomics: current status and future perspectives | |
Schärfe et al. | Genetic variation in human drug-related genes | |
Docherty et al. | Genome-wide association study of suicide death and polygenic prediction of clinical antecedents | |
Primorac et al. | Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data | |
Crews et al. | Pharmacogenomics and individualized medicine: translating science into practice | |
Gullapalli et al. | Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics | |
Hodgson et al. | Genetic differences in cytochrome P450 enzymes and antidepressant treatment response | |
Karczewski et al. | Chapter 7: pharmacogenomics | |
Finkelstein et al. | Potential utility of precision medicine for older adults with polypharmacy: a case series study | |
Piquette-Miller et al. | The art and science of personalized medicine. | |
Jarvis et al. | Consequences of CYP2D6 copy-number variation for pharmacogenomics in psychiatry | |
Parra et al. | Genome-wide association study of warfarin maintenance dose in a Brazilian sample | |
Katara et al. | Pharmacogenes (PGx-genes): current understanding and future directions | |
US20170270246A1 (en) | Method and system for calculation and graphical presentation of drug-drug or drug-biological process interactions on a smart phone, tablet or computer | |
Potamias et al. | Deciphering next-generation pharmacogenomics: an information technology perspective | |
Roden et al. | Opportunities and challenges in cardiovascular pharmacogenomics: from discovery to implementation | |
Sadee | Genomics and personalized medicine | |
Chhibber et al. | Genomic architecture of pharmacological efficacy and adverse events | |
Al-Eitan et al. | Influence of PSRC1, CELSR2, and SORT1 gene polymorphisms on the variability of warfarin dosage and susceptibility to cardiovascular disease | |
Singh et al. | The pharmacogenetics of opioid treatment for pain management | |
Chiang et al. | Data‐driven methods to discover molecular determinants of serious adverse drug events | |
Luo et al. | Comprehensive allele genotyping in critical pharmacogenes reduces residual clinical risk in diverse populations | |
Wendt et al. | Biobank scale pharmacogenomics informs the genetic underpinnings of simvastatin use | |
Paliwal et al. | Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine |